Zymeworks
Chi Wing Cheng has extensive experience in the biotechnology sector, currently serving as a Project Manager in Research at Zymeworks Inc. since September 2016, where responsibilities include the screening and characterization of antibody-drug conjugates (ADCs) and providing part-time project management support for ADC Therapeutic Development programs. Previously, Chi Wing held roles such as Senior Research Associate and Research Associate at Zymeworks, focusing on high throughput assays and assay development in discovery research. Prior experience includes positions at The Centre for Drug Research & Development, where high-throughput screening of small molecules was conducted, and research assistance at the Vancouver Prostate Centre. Chi Wing holds a Bachelor's Degree in Microbiology and Immunology from The University of British Columbia, obtained in 2016.
Zymeworks
2 followers
Zymeworks (NYSE:ZYME) is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics.